186 related articles for article (PubMed ID: 24521351)
1. Penetratin, a potentially powerful absorption enhancer for noninvasive intraocular drug delivery.
Liu C; Tai L; Zhang W; Wei G; Pan W; Lu W
Mol Pharm; 2014 Apr; 11(4):1218-27. PubMed ID: 24521351
[TBL] [Abstract][Full Text] [Related]
2. Discerning the composition of penetratin for safe penetration from cornea to retina.
Jiang K; Gao X; Shen Q; Zhan C; Zhang Y; Xie C; Wei G; Lu W
Acta Biomater; 2017 Nov; 63():123-134. PubMed ID: 28927928
[TBL] [Abstract][Full Text] [Related]
3. Facile Noninvasive Retinal Gene Delivery Enabled by Penetratin.
Liu C; Jiang K; Tai L; Liu Y; Wei G; Lu W; Pan W
ACS Appl Mater Interfaces; 2016 Aug; 8(30):19256-67. PubMed ID: 27400087
[TBL] [Abstract][Full Text] [Related]
4. Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery.
Xia H; Gao X; Gu G; Liu Z; Hu Q; Tu Y; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H
Int J Pharm; 2012 Oct; 436(1-2):840-50. PubMed ID: 22841849
[TBL] [Abstract][Full Text] [Related]
5. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.
Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M
J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720
[TBL] [Abstract][Full Text] [Related]
6. Improving corneal permeability of dexamethasone using penetration enhancing agents: First step towards achieving topical drug delivery to the retina.
Thareja A; Leigh T; Hakkarainen JJ; Hughes H; Alvarez-Lorenzo C; Fernandez-Trillo F; Blanch RJ; Ahmed Z
Int J Pharm; 2024 Jun; ():124305. PubMed ID: 38852749
[TBL] [Abstract][Full Text] [Related]
7. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.
Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure.
Bahnsen JS; Franzyk H; Sandberg-Schaal A; Nielsen HM
Biochim Biophys Acta; 2013 Feb; 1828(2):223-32. PubMed ID: 23085001
[TBL] [Abstract][Full Text] [Related]
9. A novel penetratin-modified complex for noninvasive intraocular delivery of antisense oligonucleotides.
Tai L; Liu C; Jiang K; Chen X; Feng L; Pan W; Wei G; Lu W
Int J Pharm; 2017 Aug; 529(1-2):347-356. PubMed ID: 28673859
[TBL] [Abstract][Full Text] [Related]
10. Applicability and Limitations of Cell-Penetrating Peptides in Noncovalent Mucosal Drug or Carrier Delivery Systems.
Kamei N; Bech Nielsen EJ; Nakakubo T; Aoyama Y; Rahbek UL; Pedersen BL; Takeda-Morishita M
J Pharm Sci; 2016 Feb; 105(2):747-753. PubMed ID: 26869427
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.
Kamei N; Morishita M; Eda Y; Ida N; Nishio R; Takayama K
J Control Release; 2008 Nov; 132(1):21-5. PubMed ID: 18727945
[TBL] [Abstract][Full Text] [Related]
12. Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane.
Khafagy el-S; Iwamae R; Kamei N; Takeda-Morishita M
AAPS J; 2015 Nov; 17(6):1427-37. PubMed ID: 26216471
[TBL] [Abstract][Full Text] [Related]
13. Cell penetrating peptides in ocular drug delivery: State of the art.
Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
[TBL] [Abstract][Full Text] [Related]
14. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Ex Vivo Trans-Corneal Permeation of Penetratin Analogues as Ophthalmic Carriers: Preliminary Results.
Pescina S; Sala M; Scala MC; Santi P; Padula C; Campiglia P; Ostacolo C; Nicoli S
Pharmaceutics; 2020 Aug; 12(8):. PubMed ID: 32756470
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive delivery of oligonucleotide by penetratin-modified polyplexes to inhibit protein expression of intraocular tumor.
Tai L; Liu C; Jiang K; Chen X; Wei G; Lu W; Pan W
Nanomedicine; 2017 Aug; 13(6):2091-2100. PubMed ID: 28435135
[TBL] [Abstract][Full Text] [Related]
17. Effect of cell-penetrating peptides on the nasal absorption of insulin.
Khafagy el-S; Morishita M; Isowa K; Imai J; Takayama K
J Control Release; 2009 Jan; 133(2):103-8. PubMed ID: 18930084
[TBL] [Abstract][Full Text] [Related]
18. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.
Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698
[TBL] [Abstract][Full Text] [Related]
19. Determination of the optimal cell-penetrating peptide sequence for intestinal insulin delivery based on molecular orbital analysis with self-organizing maps.
Kamei N; Kikuchi S; Takeda-Morishita M; Terasawa Y; Yasuda A; Yamamoto S; Ida N; Nishio R; Takayama K
J Pharm Sci; 2013 Feb; 102(2):469-79. PubMed ID: 23160942
[TBL] [Abstract][Full Text] [Related]
20. Cellular uptake and spread of the cell-permeable peptide penetratin in adult rat brain.
Bolton SJ; Jones DN; Darker JG; Eggleston DS; Hunter AJ; Walsh FS
Eur J Neurosci; 2000 Aug; 12(8):2847-55. PubMed ID: 10971627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
